Pure Encapsulations- Ubiquinol VESIsorb 60 caps. Premier Formulas- Your trusted source for professional-grade supplements and beauty products. Buy now for quick delivery! 100% money-back guarantee!
Ubiquinol VESIsorb is a highly bioavailable form of CoQ10, a powerful antioxidant that is essential for cellular energy production. The supplement is designed to support cardiovascular health, enhance exercise performance, and protect against oxidative stress. It contains ubiquinol, the active form of CoQ10, in a patented VESIsorb delivery system for optimal absorption.
Benefits:
- Supports cardiovascular health: CoQ10 plays a key role in energy production in the heart, and has been shown to support healthy cardiovascular function. It also helps to lower blood pressure and improve cholesterol levels.
- Enhances exercise performance: CoQ10 has been shown to improve exercise capacity and endurance, particularly in older adults.
- Protects against oxidative stress: CoQ10 is a powerful antioxidant that helps to protect against oxidative stress and damage caused by free radicals.
Dosage and Side Effects:
The recommended dosage for Ubiquinol VESIsorb is one softgel per day, taken with a meal. The supplement is generally well-tolerated, but may cause mild digestive upset in some individuals.
Ingredients:
Vitamin E (as d-alpha-tocopheryl acetate) (10IU), Ubiquinol® (Kaneka QH™ active antioxidant form of CoQ10) (100mg)
Recommended Dosage:
Warnings:
- Commitment to Quality Program
- Sourced and manufactured to avoid:
- -Artificial Additives
- -Environmental Contaminants
- -Added Excipients
- This encapsulated product contains no hidden coatings, excipients, binders, fillers, shellacs, artificial colors or fragrance. Contains no dairy, wheat, yeast, gluten, corn sugar, starch, soy, preservatives or hydrogenated oils
- Each Caplique
- Warning: If pregnant, consult your physician before taking this or any other product. Keep out of the reach of children. Tamper Resistant: use only is safety seal is intact
Reviews
There are no reviews yet.